Showing 1771-1780 of 2157 results for "".
- It's Camp Time for Dermatologistshttps://modernaesthetics.com/news/its-camp-time-for-dermatologists/2473432/As kids across the country got ready for summer camp, dermatologists flocked to Brooklyn, NY, for their own version of summer camp: Neutrogena’s immersive SkinU Summer Camp. Instead of learning to swim, sliding down a zipline, or playing tennis like kids in camp oft
- CollPlant Achieves Milestone in Dermal Filler Developmenthttps://modernaesthetics.com/news/collplant-achieves-milestone-in-dermal-filler-development/2473431/CollPlant Biotechnologies hit a milestone in the development of a regenerative dermal filler, and this achievement triggers a $10 million payment from AbbVie to CollPlant. In 2021, CollPlant and AbbVie entered into an exclusive worldwide development and commercializatio
- IL-17 Linked to Skin Aging: Studyhttps://modernaesthetics.com/news/il-17-linked-to-skin-aging-study/2473426/Interleukin (IL)-17 may plays a central role in skin aging, according to research from Institute for Research in Biomedicine (IRB Barcelona) in collaboration with the National Center for Genomic Analysis (CNAG). The study, which was led by Dr. Guiomar Solanas, Dr. Salvador Azn
- Reveal Lasers Launches Eternahttps://modernaesthetics.com/news/reveal-lasers-launches-eterna-topic/2473419/Reveal Lasers LLC is launching Eterna, a radiofrequency device that reduces fine lines and wrinkles, tightens skin through soft tissue coagulation and does not require consumables. "We are thrilled to introduce Eterna to the market," says Bob Daley, CEO of Reveal Lasers, in a
- Analysis: Millennials Drive Spending Growth in a Post-COVID Aesthetics Industryhttps://modernaesthetics.com/news/analysis-millennials-drive-spending-growth-in-a-post-covid-aesthetics-industry/2473413/The aesthetics industry is undergoing a swift transformation. Analysis of data from the last 5 years paints a clear picture of a post-pandemic shift in how the industry is addressing changing demand and the needs of a rapidly evolving customer base, according to market intelligence prov
- Evolus Acquires Exclusive US Distribution Rights to Evolysse Line of Dermal Fillershttps://modernaesthetics.com/news/evolus-acquires-exclusive-us-distribution-rights-to-evolysse-line-of-dermal-fillers/2473412/Evolus has entered into a definitive agreement to be the exclusive US distributor of a line of five dermal fillers currently in late-stage development. Evolus is partnering with Symatese, a privately held French company, to introduce the Evolysse line to its US customers beginning
- Dr. Shiv Sabesan Named CTO at Cytrellishttps://modernaesthetics.com/news/dr-shiv-sabesan-named-cto-at-cytrellis/2473409/Dr. Shiv Sabesan is Cytrellis Biosystems’ Chief Technology Officer. In his new role, Dr. Sabesan will lead the company's strategy as it continues to advance its proprietary ellacor Micro-Coring technology and expand indications. The technology was
- TAKE 5 WITH PETER KANG, CEO, COOLHEALTHhttps://modernaesthetics.com/news/take-5-with-peter-kang-ceo-coolhealth/2473406/Peter Kang, CEO of CoolHealth, chatted with Modern Aesthetics® magazine about the company and their first launch. TargetCool, a cooling device that takes cooling to the next level, provides temporary analgesia to the skin before aesthetic injections including fillers, neuromodulators, and pla
- Aquavit Files Investigational New Drug Application for Intradermal Dermatoxhttps://modernaesthetics.com/news/aquavit-files-investigational-new-drug-application-for-intradermal-dermatox/2473405/Aquavit has filed an Investigational New Drug Application with the U.S Food and Drug Administration (FDA) for Dermatox (aqubotulinumtoxinA), their intradermal injection of botulinum toxin. AqubotulinumtoxinA has already received regulatory approvals in Asia, Sou
- Dr. Arthur Swift is Advanced Medaesthetic Partners’s New CMOhttps://modernaesthetics.com/news/dr-arthur-swift-is-advanced-medaesthetic-partnerss-new-cmo/2473400/Canadian plastic surgeon Arthur Swift, MD, is Advanced Medaesthetic Partners’s new Chief Medical Officer (CMO). “Dr. Swift brings a wealth of knowledge and experience that will be a key asset for our organization,” says Nicole Chiaramonte, AMP CEO, in a news